Mesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Immunohistochemistry »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Immunoglobulins, Intravenous < Immunohistochemistry < Immunologic Deficiency Syndromes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000254 (2019) Bartlomiej Wawrzycki [Pologne] ; Dorota Krasowska [Pologne] ; Aldona Pietrzak [Pologne] ; Ewa Wielosz [Pologne] ; Maria Majdan [Pologne] ; Torello Lotti [Italie]Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
000358 (2019) Simon Galmiche [France] ; David Buob [France] ; Soraya Fellahi [France] ; Jean-Philippe Bastard [France] ; Gilles Grateau [France] ; Sophie Georgin-Lavialle [France]Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis.
000428 (2019) Cynthia M. Magro [États-Unis] ; Pierre Halteh [États-Unis] ; Luke C. Olson [États-Unis] ; Ilya Kister [États-Unis] ; Lee Shapiro [États-Unis]Linear scleroderma "en coup de sabre" with extensive brain involvement-Clinicopathologic correlations and response to anti-Interleukin-6 therapy.
000518 (2019) Sofia Kourkounti [Grèce] ; Vasilios Paparizos [Grèce] ; Theodoros Retsas [Grèce] ; Amerini Dimitrakopoulou [Grèce] ; Dimitrios Rigopoulos [Grèce]Cutaneous vasculitis in HIV-associated Castleman's disease: a rare manifestation.
000898 (2018) Chao Wang [République populaire de Chine] ; Guang Peng [République populaire de Chine] ; Hai Huang [République populaire de Chine] ; Fei Liu [République populaire de Chine] ; De-Pei Kong [République populaire de Chine] ; Ke-Qin Dong [République populaire de Chine] ; Li-He Dai [République populaire de Chine] ; Zhe Zhou [République populaire de Chine] ; Kai-Jian Wang [République populaire de Chine] ; Jun Yang [République populaire de Chine] ; Yan-Qiong Cheng [République populaire de Chine] ; Xu Gao [République populaire de Chine] ; Min Qu [République populaire de Chine] ; Hong-Ru Wang [République populaire de Chine] ; Feng Zhu [République populaire de Chine] ; Qin-Qin Tian [République populaire de Chine] ; Dan Liu [République populaire de Chine] ; Li Cao [République populaire de Chine] ; Xin-Gang Cui [République populaire de Chine] ; Chuan-Liang Xu [République populaire de Chine] ; Dan-Feng Xu [République populaire de Chine] ; Ying-Hao Sun [République populaire de Chine]Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate Cancer.
000A09 (2017) Julien Vionnet [Suisse] ; Guillaume Buss [Suisse] ; Cédric Mayer [Suisse] ; Arseny A. Sokolov [Suisse] ; François-Xavier Borruat [Suisse] ; François Spertini [Suisse]Tocilizumab for giant cell arteritis with corticosteroid-resistant progressive anterior ischemic optic neuropathy.
000A78 (2017) Noriko Kubota [Japon] ; Mikako Ito [Japon] ; Michihiro Sakauchi [Japon] ; Keiko Kobayashi [Japon]Rheumatoid neutrophilic dermatitis in a patient taking tocilizumab for treatment of rheumatoid arthritis.
000A95 (2017) Jinghua Jiang [République populaire de Chine] ; Fei Ye [République populaire de Chine] ; Xue Yang [République populaire de Chine] ; Chen Zong [République populaire de Chine] ; Lu Gao [République populaire de Chine] ; Yang Yang [République populaire de Chine] ; Qiudong Zhao [République populaire de Chine] ; Zhipeng Han [République populaire de Chine] ; Lixin Wei [République populaire de Chine]Peri-tumor associated fibroblasts promote intrahepatic metastasis of hepatocellular carcinoma by recruiting cancer stem cells.
000B80 (2017) Shunsei Hirohata [Japon] ; Asami Abe [Japon] ; Akira Murasawa [Japon] ; Toshihisa Kanamono ; Tetsuya Tomita [Japon] ; Hideki Yoshikawa [Japon]Differential effects of IL-6 blockade tocilizumab and TNF inhibitors on angiogenesis in synovial tissues from patients with rheumatoid arthritis.
000D32 (2016) Avinash Sharma [Inde] ; Anju Gupta [Inde] ; Suvradeep Mitra [Inde] ; Ritambhra Nada [Inde] ; Sagar Bhattad [Inde] ; Surjit Singh [Inde]Systemic Juvenile Idiopathic Arthritis with Amyloidosis: An Uncommon Complication with a Favourable Outcome.
000F10 (2016) Akiha Inoue [Japon] ; Yu Sawada ; Shun Ohmori ; Daisuke Omoto ; Sanehito Haruyama ; Manabu Yoshioka ; Daisuke Nishio ; Motonobu NakamuraCD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.
001089 (2015) Nicolas H. Pope [États-Unis] ; Morgan Salmon [États-Unis] ; William F. Johnston [États-Unis] ; Guanyi Lu [États-Unis] ; Christine L. Lau [États-Unis] ; Gilbert R. Upchurch [États-Unis] ; Gorav Ailawadi [États-Unis]Interleukin-6 Receptor Inhibition Prevents Descending Thoracic Aortic Aneurysm Formation.
001274 (2014) Glynn Dennis ; Cécile T J. Holweg ; Sarah K. Kummerfeld ; David F. Choy ; A Francesca Setiadi ; Jason A. Hackney ; Peter M. Haverty ; Houston Gilbert ; Wei Yu Lin ; Lauri Diehl ; S. Fischer ; An Song ; David Musselman ; Micki Klearman ; Cem Gabay ; Arthur Kavanaugh ; Judith Endres ; David A. Fox ; Flavius Martin ; Michael J. TownsendSynovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.
001426 (2014) Sudipto Das [Royaume-Uni] ; Edward M. Vital ; Sarah Horton ; Domini Bryer ; Yasser El-Sherbiny ; Andrew C. Rawstron ; Frederique Ponchel ; Paul Emery ; Maya H. BuchAbatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy.
001894 (2011) Christoph Garbers [Allemagne] ; Wolfgang Thaiss ; Gareth W. Jones ; Georg H. Waetzig ; Inken Lorenzen ; Florence Guilhot ; Rami Lissilaa ; Walter G. Ferlin ; Joachim Grötzinger ; Simon A. Jones ; Stefan Rose-John ; Jürgen SchellerInhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
001A70 (2009) Yukio Mano [Japon] ; Kiyosumi Shibata ; Seiji Sumigama ; Hiromi Hayakawa ; Kazuhiko Ino ; Eiko Yamamoto ; Hiroaki Kajiyama ; Akihiro Nawa ; Fumitaka KikkawaTocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and -9 secretions from human amnion cells in preterm premature rupture of membranes.
001B14 (2009) Mareina Kudo [Japon] ; Hirofumi Jono ; Satoru Shinriki ; Shigetoshi Yano ; Hideo Nakamura ; Keishi Makino ; Takuichiro Hide ; Daisuke Muta ; Mitsuharu Ueda ; Kazutoshi Ota ; Yukio Ando ; Jun-Ichi KuratsuAntitumor effect of humanized anti-interleukin-6 receptor antibody (tocilizumab) on glioma cell proliferation. Laboratory investigation.
001B54 (2008) M. Hashizume [Japon] ; N. Hayakawa ; M. MiharaIL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Immunohistochemistry" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Immunohistochemistry" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Immunohistochemistry
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021